- Home
- LFWD vs BOLT Comparison
LFWD vs BOLT Comparison
Compare LFWD & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFWD
- BOLT
- Stock Information
- Founded
- LFWD 2001
- BOLT 2015
- Country
- LFWD Israel
- BOLT United States
- Employees
- LFWD N/A
- BOLT N/A
- Industry
- LFWD
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- LFWD
- BOLT Health Care
- Exchange
- LFWD NYSE
- BOLT Nasdaq
- Market Cap
- LFWD 14.9M
- BOLT 16.8M
- IPO Year
- LFWD 2014
- BOLT 2021
- Fundamental
- Price
- LFWD $1.48
- BOLT $0.37
- Analyst Decision
- LFWD Strong Buy
- BOLT Hold
- Analyst Count
- LFWD 3
- BOLT 5
- Target Price
- LFWD $9.00
- BOLT $1.13
- AVG Volume (30 Days)
- LFWD 182.3K
- BOLT 145.0K
- Earning Date
- LFWD 05-14-2025
- BOLT 05-13-2025
- Dividend Yield
- LFWD N/A
- BOLT N/A
- EPS Growth
- LFWD N/A
- BOLT N/A
- EPS
- LFWD N/A
- BOLT N/A
- Revenue
- LFWD $25,663,000.00
- BOLT $7,690,000.00
- Revenue This Year
- LFWD $16.16
- BOLT N/A
- Revenue Next Year
- LFWD $51.10
- BOLT $77.45
- P/E Ratio
- LFWD N/A
- BOLT N/A
- Revenue Growth
- LFWD 85.24
- BOLT N/A
- 52 Week Low
- LFWD $1.22
- BOLT $0.30
- 52 Week High
- LFWD $5.28
- BOLT $1.34
- Technical
- Relative Strength Index (RSI)
- LFWD 46.83
- BOLT 48.52
- Support Level
- LFWD $1.37
- BOLT $0.33
- Resistance Level
- LFWD $1.50
- BOLT $0.39
- Average True Range (ATR)
- LFWD 0.11
- BOLT 0.04
- MACD
- LFWD 0.00
- BOLT 0.00
- Stochastic Oscillator
- LFWD 57.78
- BOLT 66.06
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.